Breaking News Instant updates and real-time market news.

KITE

Kite Pharma

$51.80

1.24 (2.45%)

09:22
11/21/16
11/21
09:22
11/21/16
09:22

Kite to present interim results from ZUMA-1 pivotal trial at ASH meeting

Kite Pharma announced that data from the interim analysis of the pivotal ZUMA-1 trial of KTE-C19 in patients with chemorefractory aggressive non-Hodgkin lymphoma have been accepted as an oral late-breaking presentation at the American Society of Hematology, or ASH, 58th Annual Meeting in San Diego, CA, on December 6, 2016. The abstract was one of only six accepted in this category and will be included in the December 1 online issue of Blood. Kite reports that KTE-C19 significantly improved Objective Response Rate in patients with Chemorefractory DLBCL at pre-defined interim analysis. "Outcomes for patients with aggressive NHL depend on whether their disease is sensitive to chemotherapy. The ZUMA-1 study was designed to support registration of KTE-C19 by enrolling a well-defined chemorefractory patient population. We are pleased with the outcome of the study to date and thank the patients and investigators for their participation in the first positive pivotal study in CAR-T therapy," said Jeff Wiezorek, M.D., Senior VP of Clinical Development of Kite.

  • 03

    Dec

  • 03

    Dec

KITE Kite Pharma
$51.80

1.24 (2.45%)

10/07/16
GSCO
10/07/16
NO CHANGE
GSCO
Smid-cap Biotech sector upgraded to Attractive from Neutral at Goldman
Goldman analyst Salveen Richter upgraded the Smid-cap biotechnology to Attractive and said he favors and companies with near-term pipeline data or regulatory events where he has conviction.Names he recommends are Buy rated BioMarin (BMRN), bluebird bio (BLUE), GW Pharma (GWPH), Incyte (INCY), Kite (KITE), and Sage (SAGE).
10/10/16
ADAM
10/10/16
NO CHANGE
Target $75
ADAM
Buy
Kite Pharma BLA filing still expected by year end, says Canaccord
Canaccord analyst John Newman noted Kite Pharma released 12 month update on Zuma-1 Phase 1, which showed durable efficacy and is encouraging despite coming from a small patient group. The analyst saw the release as a continuation of positive trends and expects a BLA filing by the end of 2016. Newman reiterated his Buy rating and $75 price target on Kite Pharma shares.
11/10/16
RBCM
11/10/16
NO CHANGE
RBCM
Kite Pharma weakness creates buying opportunity, says RBC Capital
After Kite's stock fell recently, RBC Capital analyst Michael Yee blames the pullback on macro worries about the biotech sector and a number of "short-term questions," about several issues, including upcoming ASH data, new durability data expected next quarter, and questions about the FDA's view of its drug. However, the analyst thinks that the company's comments indicate that its talks with the FDA are going well, and he says he remains upbeat on the company's pipeline. He expects "a lot" of concerns about the company to be mitigated in the next three to six m,months, as he thinks that it will report positive data in the near to medium term.The analyst keeps an $85 price target and an Outperform rating on the shares.
11/21/16
HCWC
11/21/16
INITIATION
Target $78
HCWC
Buy
Kite Pharma initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Corey Davis started Kite Pharma with a Buy rating and $78 price target. While the competition for Chimeric Antigen Receptor T-cells is intense, Kite should have a big first-mover advantage with KTE-C19, Davis tells investors in a research note.

TODAY'S FREE FLY STORIES

SPY

SPDR S&P 500 ETF Trust

$243.63

2.3 (0.95%)

, SPX

S&P 500

13:43
06/28/17
06/28
13:43
06/28/17
13:43
Technical Analysis
Technical View: S&P 500 rebounds sharply, still within established range »

The sharp downward drop…

SPY

SPDR S&P 500 ETF Trust

$243.63

2.3 (0.95%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBI

CB&I

$20.79

0.7683 (3.84%)

13:40
06/28/17
06/28
13:40
06/28/17
13:40
Options
Call buyer opens a big new position in Chicago Bridge and Iron »

Call buyer opens a big…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:40
06/28/17
06/28
13:40
06/28/17
13:40
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

EGO

Eldorado Gold

$2.72

-0.1 (-3.55%)

13:37
06/28/17
06/28
13:37
06/28/17
13:37
Downgrade
Eldorado Gold rating change  »

Eldorado Gold downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

GOOS

Canada Goose

$20.60

-0.49 (-2.32%)

13:30
06/28/17
06/28
13:30
06/28/17
13:30
Upgrade
Canada Goose rating change  »

Canada Goose upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

13:25
06/28/17
06/28
13:25
06/28/17
13:25
Conference/Events
JPMorgan life sciences analyst holds an analyst/industry conference call »

Life Science Tools &…

MU

Micron

$31.66

-0.84 (-2.58%)

13:24
06/28/17
06/28
13:24
06/28/17
13:24
Hot Stocks
Nanya Technology lowers Micron stake to 4.17% with recent sale of 11.6M shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 29

    Aug

BPY

Brookfield Property

$24.08

0.34 (1.43%)

13:22
06/28/17
06/28
13:22
06/28/17
13:22
Conference/Events
Brookfield Property management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

13:20
06/28/17
06/28
13:20
06/28/17
13:20
General news
Treasury's $28 B 7-year auction results fell to the soft side »

Treasury's $28 B…

BPOP

Popular

$39.33

0.16 (0.41%)

13:19
06/28/17
06/28
13:19
06/28/17
13:19
Conference/Events
Popular management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 26

    Sep

  • 27

    Sep

$NSD

NASDAQ Market Internals

13:17
06/28/17
06/28
13:17
06/28/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEOH

Methanex

$42.30

0.4 (0.95%)

13:16
06/28/17
06/28
13:16
06/28/17
13:16
Conference/Events
Methanex management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

$NYE

NYSE Market Internals

13:16
06/28/17
06/28
13:16
06/28/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
06/28/17
06/28
13:15
06/28/17
13:15
General news
Treasury Action: intermediate yields ticked higher »

Treasury Action:…

CS

Credit Suisse

$14.45

0.2 (1.40%)

13:14
06/28/17
06/28
13:14
06/28/17
13:14
Syndicate
Breaking Syndicate news story on Credit Suisse »

Credit Suisse files $85B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMGN

ImmunoGen

$6.54

-0.28 (-4.11%)

13:12
06/28/17
06/28
13:12
06/28/17
13:12
Conference/Events
ImmunoGen management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

VZ

Verizon

$44.85

0.005 (0.01%)

, GOOG

Alphabet

$927.33

-24.94 (-2.62%)

13:09
06/28/17
06/28
13:09
06/28/17
13:09
Periodicals
Verizon explores pooling consumer data with other wireless firms, BI says »

After closing its…

VZ

Verizon

$44.85

0.005 (0.01%)

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

FB

Facebook

$150.58

-3.01 (-1.96%)

TMUS

T-Mobile

$61.01

-2.14 (-3.39%)

S

Sprint

$8.14

-0.04 (-0.49%)

VOD

Vodafone

$28.65

-0.145 (-0.50%)

TEF

Telefonica

$10.53

-0.1 (-0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

  • 27

    Jul

  • 03

    Aug

MIC

Macquarie Infrastructure

$79.18

0.8299 (1.06%)

13:09
06/28/17
06/28
13:09
06/28/17
13:09
Conference/Events
Macquarie Infrastructure management to meet with RBC Capital »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 18

    Jul

  • 19

    Jul

13:05
06/28/17
06/28
13:05
06/28/17
13:05
General news
7-Yr Note Auction Coupon Rate data reported »

7-Yr Note Auction Coupon…

13:05
06/28/17
06/28
13:05
06/28/17
13:05
General news
7-Yr Note Auction Total Amount data reported »

7-Yr Note Auction Total…

13:05
06/28/17
06/28
13:05
06/28/17
13:05
General news
Treasury Option Action: bullish 10-year positioning »

Treasury Option Action:…

MTCH

Match Group

$17.50

-0.295 (-1.66%)

13:04
06/28/17
06/28
13:04
06/28/17
13:04
Hot Stocks
Tinder introduces Tinder Gold premium service »

Match Group's Tinder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAD

Rite Aid

$4.04

0.2989 (7.99%)

, WBA

Walgreens Boots Alliance

$77.26

-0.27 (-0.35%)

13:02
06/28/17
06/28
13:02
06/28/17
13:02
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

RAD

Rite Aid

$4.04

0.2989 (7.99%)

WBA

Walgreens Boots Alliance

$77.26

-0.27 (-0.35%)

MKC

McCormick

$98.40

-0.135 (-0.14%)

LNN

Lindsay

$87.92

1.32 (1.52%)

GBX

Greenbrier

$50.15

0.7 (1.42%)

CAG

Conagra Brands

$37.53

0.525 (1.42%)

STZ

Constellation Brands

$183.93

1.65 (0.91%)

AYI

Acuity Brands

$180.03

4.695 (2.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 07

    Jul

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

, GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

13:02
06/28/17
06/28
13:02
06/28/17
13:02
Periodicals
Alphabet sought to sell Nest last year, Reuters reports »

At a certain point in…

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

PIR

Pier 1 Imports

$5.42

0.0799 (1.50%)

, SHLM

A. Schulman

$27.50

-1.05 (-3.68%)

13:02
06/28/17
06/28
13:02
06/28/17
13:02
Earnings
Notable companies reporting after market close »

Notable companies…

PIR

Pier 1 Imports

$5.42

0.0799 (1.50%)

SHLM

A. Schulman

$27.50

-1.05 (-3.68%)

PRGS

Progress Software

$30.08

-0.16 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.